I.CERAM SA (FR:ALICR) has released an update.
I.CERAM SA has announced their definitive financial results for fiscal year 2023, showing a significant decline in revenue and gross margin, and a net loss of €1,104 thousand. Amidst financial struggles, the company has entered judicial recovery with a six-month observation period initiated by the commercial court of Limoges. Despite the challenges, I.CERAM emphasizes its continued innovation in antibiotic-loaded ceramic implants and expects future growth with products awaiting reimbursement decisions and market launches.
For further insights into FR:ALICR stock, check out TipRanks’ Stock Analysis page.